Table 1. Baseline characteristics of women screened for PrEP, by male-partner HIV status (N = 1,271) (N [%] or median [IQR]).
| Reported male-partner HIV status | ||||
|---|---|---|---|---|
| Characteristics | Overall (N = 1,271) | Negative (n = 772; 61%) | Unknown (n = 427; 34%) | Positive (n = 65; 5%) |
| Age | 25 (22–29) | 24.0 (22.0–29.0) | 24.0 (21.0–29.0) | 30.0 (25.0–35.0) |
| Age category (years) | ||||
| <20 | 105 (8.3) | 62 (8.0%) | 36 (8.4%) | 4 (6.2%) |
| 20–24 | 522 (41.1) | 333 (43.1%) | 178 (41.7%) | 10 (15.4%) |
| 25–29 | 356 (28.0) | 221 (28.6%) | 119 (27.9%) | 13 (20.0%) |
| 30–34 | 172 (13.5) | 103 (13.3%) | 50 (11.7%) | 19 (29.2%) |
| ≥35 | 116 (9.1) | 53 (6.9%) | 44 (10.3%) | 19 (29.2%) |
| Marital status | ||||
| Married/cohabiting | 1,026 (81.8) | 648 (84.9) | 318 (75.5) | 60 (93.8) |
| Not married/cohabiting | 229 (18.2) | 115 (15.1) | 103 (24.5) | 4 (6.2) |
| Missing | 16 (1.3%) | 9 (1.2%) | 6 (1.4%) | 1 (1.5%) |
| Marriage type (n = 1,011) | ||||
| Polygamous | 956 (94.6) | 620 (97.0) | 287 (91.7) | 49 (83.1) |
| Monogamous | 55 (5.4) | 19 (3.0) | 26 (8.3) | 10 (16.9) |
| Clinical characteristics | ||||
| Any FP method | 1,121 (91.8) | 706 (93.6) | 375 (91.9) | 36 (69.2) |
| Contraceptive type1 (n = 1,117) | ||||
| Injectable | 627 (55.9) | 391 (55.4) | 216 (57.6) | 19 (52.8) |
| Implant | 345 (30.8) | 224 (31.7) | 104 (27.7) | 14 (38.9) |
| OCP | 60 (5.4) | 34 (4.8) | 26 (6.9) | 0 (0.0) |
| IUD | 37 (3.3) | 26 (3.7) | 11 (2.9) | 0 (0.0) |
| Condoms only | 27 (2.4) | 16 (2.3) | 9 (2.4) | 2 (5.6) |
| Other method2 | 18 (1.6) | 11 (1.6) | 6 (1.6) | 1 (2.8) |
| Missing | 7 (0.6) | 4 (0.6) | 3 (0.8) | 0 (0.0) |
| Behavioral risk factors in last 6 month | ||||
| Had sex without a condom | 1,200 (94.4) | 736 (95.3) | 401 (93.9) | 57 (87.7) |
| Engaged in sex in exchange for money/favors | 13 (1.0) | 4 (0.5) | 5 (1.2) | 4 (6.2) |
| Diagnosed with or treated for an STI | 14 (1.1) | 5 (0.6) | 8 (1.9) | 1 (1.5) |
| Forced to have sex | 21 (1.7) | 4 (0.5) | 11 (2.6) | 6 (9.2) |
| Experienced IPV | 46 (3.6) | 11 (1.4) | 29 (6.8) | 6 (9.2) |
| Shared needles while engaging in IVD | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Recurrent PEP use | 2 (0.2) | 1 (0.1) | 1 (0.2) | 0 (0.0) |
1Among women who reported using at least one method of FP (n = 1,117).
2Other methods specified included locational amenorrhea, withdrawal, natural methods, and tubal ligation.
Abbreviations: FP, family planning; IPV, intimate partner violence; IQR, interquartile range; IUD, intrauterine device; IVD, intravenous drug use; OCP, oral contraception pill; PEP, postexposure prophylaxis; PrEP, preexposure prophylaxis; STI, sexually transmitted infection